320 related articles for article (PubMed ID: 16802332)
41. Fetal striatum- and ventral mesencephalon-derived expanded neurospheres rescue dopaminergic neurons in vitro and the nigro-striatal system in vivo.
Moses D; Drago J; Teper Y; Gantois I; Finkelstein DI; Horne MK
Neuroscience; 2008 Jun; 154(2):606-20. PubMed ID: 18472226
[TBL] [Abstract][Full Text] [Related]
42. Manganese does not alter the severe neurotoxicity of MPTP.
Baek SY; Kim YH; Oh SO; Lee CR; Yoo CI; Lee JH; Lee H; Sim CS; Park J; Kim JW; Yoon CS; Kim Y
Hum Exp Toxicol; 2007 Mar; 26(3):203-11. PubMed ID: 17439923
[TBL] [Abstract][Full Text] [Related]
43. Pathogenic role of glial cells in Parkinson's disease.
Teismann P; Tieu K; Cohen O; Choi DK; Wu DC; Marks D; Vila M; Jackson-Lewis V; Przedborski S
Mov Disord; 2003 Feb; 18(2):121-9. PubMed ID: 12539204
[TBL] [Abstract][Full Text] [Related]
44. Activated microglia affect the nigro-striatal dopamine neurons differently in neonatal and aged mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Sawada H; Hishida R; Hirata Y; Ono K; Suzuki H; Muramatsu S; Nakano I; Nagatsu T; Sawada M
J Neurosci Res; 2007 Jun; 85(8):1752-61. PubMed ID: 17469135
[TBL] [Abstract][Full Text] [Related]
45. Regulation of astroglial-derived dopaminergic neurotrophic factors by interleukin-1 beta in the striatum of young and middle-aged mice.
Ho A; Blum M
Exp Neurol; 1997 Nov; 148(1):348-59. PubMed ID: 9398477
[TBL] [Abstract][Full Text] [Related]
46. Fucoidan protects against dopaminergic neuron death in vivo and in vitro.
Luo D; Zhang Q; Wang H; Cui Y; Sun Z; Yang J; Zheng Y; Jia J; Yu F; Wang X; Wang X
Eur J Pharmacol; 2009 Sep; 617(1-3):33-40. PubMed ID: 19545563
[TBL] [Abstract][Full Text] [Related]
47. Simvastatin prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced striatal dopamine depletion and protein tyrosine nitration in mice.
Selley ML
Brain Res; 2005 Mar; 1037(1-2):1-6. PubMed ID: 15777746
[TBL] [Abstract][Full Text] [Related]
48. A subpopulation of reactive astrocytes at affected neuronal perikarya after hypophysectomy in adult rats.
Yuan Q; Scott DE; So KF; Wu W
Brain Res; 2007 Jul; 1159():18-27. PubMed ID: 17573051
[TBL] [Abstract][Full Text] [Related]
49. Adrenalectomy counteracts the local modulation of astroglial fibroblast growth factor system without interfering with the pattern of 6-OHDA-induced dopamine degeneration in regions of the ventral midbrain.
Chadi G; Silva C; Maximino JR; Fuxe K; da Silva GO
Brain Res; 2008 Jan; 1190():23-38. PubMed ID: 18086466
[TBL] [Abstract][Full Text] [Related]
50. Activation of tyrosine kinase receptor signaling pathway by rasagiline facilitates neurorescue and restoration of nigrostriatal dopamine neurons in post-MPTP-induced parkinsonism.
Sagi Y; Mandel S; Amit T; Youdim MB
Neurobiol Dis; 2007 Jan; 25(1):35-44. PubMed ID: 17055733
[TBL] [Abstract][Full Text] [Related]
51. Differential effects of growth/differentiation factor 5 and glial cell line-derived neurotrophic factor on dopaminergic neurons and astroglia in cultures of embryonic rat midbrain.
Wood TK; McDermott KW; Sullivan AM
J Neurosci Res; 2005 Jun; 80(6):759-66. PubMed ID: 15880784
[TBL] [Abstract][Full Text] [Related]
52. Activated Notch1 is a stronger astrocytic stimulus than leukemia inhibitory factor for rat neural stem cells.
Rodríguez-Rivera NS; Molina-Hernández A; Sánchez-Cruz E; Escalante-Alcalde D; Velasco I
Int J Dev Biol; 2009; 53(7):947-53. PubMed ID: 19378247
[TBL] [Abstract][Full Text] [Related]
53. The effect of dopamine agonists: the expression of GDNF, NGF, and BDNF in cultured mouse astrocytes.
Ohta K; Kuno S; Inoue S; Ikeda E; Fujinami A; Ohta M
J Neurol Sci; 2010 Apr; 291(1-2):12-6. PubMed ID: 20129627
[TBL] [Abstract][Full Text] [Related]
54. The neuronal mechanism underlying parkinsonism and dyskinesia, and differential roles of the putamen and caudate nucleus.
Yoshida M
Adv Neurol; 1993; 60():71-7. PubMed ID: 8380531
[TBL] [Abstract][Full Text] [Related]
55. Pyrethroid and organophosphate insecticide exposure in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease: an immunohistochemical analysis of tyrosine hydroxylase and glial fibrillary acidic protein in dorsolateral striatum.
Dodd CA; Klein BG
Toxicol Ind Health; 2009 Feb; 25(1):25-39. PubMed ID: 19318502
[TBL] [Abstract][Full Text] [Related]
56. Neurotrophic actions of the novel AMPA receptor potentiator, LY404187, in rodent models of Parkinson's disease.
O'Neill MJ; Murray TK; Whalley K; Ward MA; Hicks CA; Woodhouse S; Osborne DJ; Skolnick P
Eur J Pharmacol; 2004 Feb; 486(2):163-74. PubMed ID: 14975705
[TBL] [Abstract][Full Text] [Related]
57. Modification of the number and phenotype of striatal dopaminergic cells by carotid body graft.
San Sebastián W; Guillén J; Manrique M; Belzunegui S; Ciordia E; Izal-Azcárate A; Garrido-Gil P; Vázquez-Claverie M; Luquin MR
Brain; 2007 May; 130(Pt 5):1306-16. PubMed ID: 17439984
[TBL] [Abstract][Full Text] [Related]
58. Effects of nimodipine on the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced depletions in the biogenic amine levels in mice.
Gerlach M; Russ H; Winker J; Witzmann K; Traber J; Stasch JP; Riederer P; Przuntek H
Arzneimittelforschung; 1993 Apr; 43(4):413-5. PubMed ID: 7684224
[TBL] [Abstract][Full Text] [Related]
59. Progenitor proliferation in the adult hippocampus and substantia nigra induced by glial cell line-derived neurotrophic factor.
Chen Y; Ai Y; Slevin JR; Maley BE; Gash DM
Exp Neurol; 2005 Nov; 196(1):87-95. PubMed ID: 16112112
[TBL] [Abstract][Full Text] [Related]
60. Glia cell number modulates sensitivity to MPTP in mice.
Smeyne M; Jiao Y; Shepherd KR; Smeyne RJ
Glia; 2005 Nov; 52(2):144-52. PubMed ID: 15920722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
